Stock Events

Stock Events

GL Pharm Tech 

₩3,425
2
-₩70-2% 06:30 Today

Statistics

Day High
3,485
Day Low
3,290
52W High
6,555
52W Low
3,290
Volume
28,024
Avg. Volume
64,940
Mkt Cap
265.61B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Mar 31Expected
Q2 2016
Q3 2016
Q4 2016
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-130
-90
-50
-10
Expected EPS
N/A
Actual EPS
-51

Financials

-0.2%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
19.14BRevenue
-38.47MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Celltrion Pharm
068760.KQ
Mkt Cap1.74T
Celltrion Pharm Inc. - Specializes in the development and manufacturing of pharmaceutical products, competing in the South Korean market.
Seegene
096530.KQ
Mkt Cap1.3T
SillaJen, Inc. - Focuses on biopharmaceuticals, particularly in the therapeutic areas that overlap with GL Pharm Tech's interests.
Celltrion Health Care
091990.KQ
Mkt Cap11.33T
Celltrion Healthcare Co., Ltd. - Distributes biopharmaceutical drugs, directly competing in the market segments targeted by GL Pharm Tech.
Ildong Pharm
249420.KQ
Mkt Cap0
JW Shinyak Corporation - Engages in pharmaceutical manufacturing and sales, competing in the same regional market as GL Pharm Tech.

About

GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further, it provides Cabalin CR extended-release tablet and Jample Ibufen syrup for the nervous system and sensory organs; Gisoren tablets for individual organs, digestive system, and peptic ulcer drugs; and Genstring Troki for treating individual organs and digestive system, as well as oral use. GL Pharm Tech Corp. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
Show More
CEO
Mr. Yong-Il Kim
Employees
33
Country
South Korea
ISIN
KR7204840003

Listings

KQ
KR
204840.KQ

0 Comments

Share your thoughts

FAQs

What is GL Pharm Tech stock price today?▼
The current price of 204840.KQ is ₩3,425 KRW — it has decreased by -2% in the past 24 hours. Watch GL Pharm Tech stock price performance more closely on the chart.
What is GL Pharm Tech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange GL Pharm Tech stocks are traded under the ticker 204840.KQ.
Is GL Pharm Tech stock price growing?▼
204840.KQ stock has fallen by -4.33% compared to the previous week, the month change is a -18.45% fall, over the last year GL Pharm Tech has showed a -41.9% decrease.
What is GL Pharm Tech market cap?▼
Today GL Pharm Tech has the market capitalization of 265.61B
What were GL Pharm Tech earnings last quarter?▼
204840.KQ earnings for the last quarter are -51 KRW per share, whereas the estimation was N/A KRW resulting in a N/A surprise. The estimated earnings for the next quarter are N/A KRW per share.
What is GL Pharm Tech revenue for the last year?▼
GL Pharm Tech revenue for the last year amounts to 19.14B KRW.
What is GL Pharm Tech net income for the last year?▼
204840.KQ net income for the last year is -38.47M KRW.
How many employees does GL Pharm Tech have?▼
As of November 3, 2026, the company has 33 employees.
In which sector is GL Pharm Tech located?▼
GL Pharm Tech operates in the Energy sector.
When did GL Pharm Tech complete a stock split?▼
The last stock split for GL Pharm Tech was on August 11, 2026 with a ratio of 1:5.
Where is GL Pharm Tech headquartered?▼
GL Pharm Tech is headquartered in Seongnam-si, South Korea.